Because 4SC-202 affects the cell population(s) that express CD133, FOXM1, and SOX2 and there is strong evidence that these proteins are cancer stem cell markers, our data suggest that 4SC-202 may decrease the cancer stem-like cell population. This evidence concerns the gene FOXM1 and cancer.